Q1 2018

Source filing unavailable

Q1 2018 · —

Revenue

€3.98B

−12.6% vs Q1 2017

Net Income

€278.56M

−9.6% vs Q1 2017

EPS Diluted

€0.91

−9.0% vs Q1 2017

Gross Profit€1,202,749,000−24.4%

Operating Income€496,876,000−23.7%

Operating Cash Flow-€44,808,000

Same quarter

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR